Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-08-02
2008-11-18
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S317000, C530S333000
Reexamination Certificate
active
07452862
ABSTRACT:
Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
REFERENCES:
patent: 3997540 (1976-12-01), Mehta et al.
patent: 6011155 (2000-01-01), Villhauer
patent: 6165985 (2000-12-01), Jasserand et al.
patent: 6479460 (2002-11-01), Bab et al.
patent: 6548501 (2003-04-01), Hakkinen
patent: 6852722 (2005-02-01), Hakkinen
patent: 2005/0049234 (2005-03-01), Deslongchamps et al.
patent: 2005/0054562 (2005-03-01), Fraser et al.
patent: 2005/0119169 (2005-06-01), Deslongchamps et al.
patent: 2235377 (1973-02-01), None
patent: 1365201 (1974-08-01), None
patent: WO-96/22304 (1996-07-01), None
patent: WO-97/48713 (1997-12-01), None
patent: WO-98/46631 (1998-10-01), None
patent: WO-98/54577 (1998-12-01), None
patent: WO-01/25257 (2001-04-01), None
patent: WO-02/08250 (2002-01-01), None
Siani, Michael A., et al., “Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore”, Journal of Molecular Graphics and Modelling, vol. 18, 2000, pp. 497-511.
Sato, Takeo, et al., “Medium-sized Cyclophanes. Part XV. 10,15-Dihydro-5H-tribenzo-[a,d,g]cyclononene and Analogues”, J. Chem. Soc. Perkin I, 1973, pp. 895-900.
Romanovaskis, et al., “Preparation of head-to-tail cyclic peptides via side-chain attachment: Implications for library synthesis”, J. Peptide Res., vol. 52, 1998, pp. 356-374.
Horton, Douglas A., et al., “Exploring privileged structures: The combinatorial synthesis of cyclic peprides”, Molecular Diversity, 2002, vol. 5, pp. 289-304.
Wenlock, Mark C., et al., “A Comparison of Physciochemical Property Profiles of Development and Marketed Oral Drugs”, J. Med. Chem., 2003, vol. 46, pp. 1250-1256.
Veber, Daniel F., et al., “Molecular Properties That Influence the Oral Bioavailability o Drug Candidates”, J. Med. Chem. 2002, vol. 45, pp. 2615-2623.
Mori, Kenji, et al., “Synthesis of Moncerin, an Antifungal, Insecticidal and Phytotoxic Heptaketide Metabolite of Excerohilum Monoceras”, Tetrahedron, 1989, vol. 45, No. 6, pp. 1639-1646.
Kogan, Timothy P., et al., “A Regio- and Stereocontrolled Total Synthesis of (-)-Indolactam-V”, Tetrahedron, 1990, vol. 46, No. 19, pp. 6623-6632.
Knapp, Spencer, et al., “Synthesis of Hypusine and Other Polyamines Using Dibenzyltriazones for Amino Protection”, J. Org. Chem., 1992, vol. 57, pp. 6239-6256.
Boger, Dale L., et al., “Total Synthesis of HUN-7293”, J. Am. Chem. Soc., 1999, vol. 121, pp. 6197-6205.
Bednarek, Maria A., et al., “Structure-Function Studies on the New Growth Hormone- Releasing Peptide, Ghrelin: Minimal Sequence of Ghrelin Necessary for Activiation of Growth Hormone Secretagogue Receptor 1a”, J. Med. Chem., 2000, vol. 43, pp. 4370-4376.
Palucki, Brenda L., et al., “Spiro(indoline-3,4′-piperidine) Growth Hormone Secretagogues as Ghrelin Mimetics”, Bioorganic & Medicinal Chemistry Letters, 2001, vol. 11, pp. 1955-1957.
Davies, John S., “The Cyclization of Peptides and Depsipeptides”, Journal of Peptide Science, vol. 9, 2003, pp. 471-501.
Suat Kee, et al., “Design of β-tum Based Therapeutic Agents”, Current Pharmaceutical Design, 2003, vol. 9, pp. 1209-1224.
Eguchi, Masakatsu, et al., “Design, Synthesis, and Application of Peptide Secondary Structure Mimetics”, Mini Reviews in Medicinal Chemistry, 2002, vol. 2, pp. 447-462.
Glenn, Matthew P., et al., “Mimetics of the Peptide β-Strand”, Mini Reviews in Medicinal Chemistry, 2002, vol. 2, pp. 433-445.
Li, Peng et al., “Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization”, Current Organic Chemistry, 2002, vol. 6, pp. 411-440.
Souers, Andrew J., et al., “β-Turn mimetic library synthesis: scaffolds and applications”, Tetrahedron 57, 2001, pp. 7431-7448.
Tyndall, Joel D.A., et al., “Macrocycles Mimic the Extended Peptide Conformation Recognized by Aspartic, Serine, Cysteine and Metallo Proteases”, Current Medicinal Chemistry, 2001, vol. 8, pp. 893-907.
Burgess, Kevin, “Solid-Phase Syntheses of β-Turn Analogues to Mimic or Disrupt Protein—Protein Interactions”, Acc. Chem. Res., 2001, vol. 34, pp. 826-835.
Lambert, John N., et al., “The synthesis of cyclic peptides”, J. Chem. Soc., Perkin Trans. 1, 2001, pp. 471-484.
MacDonald, Mary, et al., “Approaches to Cyclic Peptide β-Turn Mimics”, Current Organic Chemistry, 2001, vol. 5, pp. 417-438.
Kim, Hwa-Ok, et al., “A Merger of Rational Drug Design and Combinatorial Chemistry: Development and Application of Peptide Secondary Structure Mimetics”, Combinatorial Chemistry & High Throughput Screening, 2000, vol. 3, pp. 167-183.
EPO Supplementary Partial European Search Report for EP 04 76 1605, Jul. 25, 2006.
Haramura, M, et al., Design and synthesis of N-terminal cyclic motilin partial peptides: a novel pure motilin antagonist, Chemical and Pharmaceutical Bulletin (Jan. 2001), pp. 40-43, 49:1.
Inge Depoortere, et al., Interaction of the growth hormone-releasing peptides ghrelin and growth-hormone releasing peptide-6 with motilin receptor in the rabbit gastric antrum, The Journal of Pharmacology and Experimental Therapeutics (2003), pp. 660-666, 305:2.
Khiat, A, et al., Identification of the motilide pharmacophores using quantitative structure activity relationships, Journal of Peptide Research (Oct. 1, 1998), pp. 321-328, 52:4.
Koga, H, et al., Macrolide-type motilin receptor agonists: assessment of the biological value of the 2′- and 4″-hydroxyl groups of acid-stable 8,9-anhydroerythromycin A 6,9- hemiacetals, Bioorganic & Medicinal Chemistry Letters (1994), pp. 1649-1654, 4:13.
Haramura, M, et al., Design and synthesis of motilin antagonists derived from the [1,4] fragment of porcine motilin, Journal of Medicinal Chemistry (Jan. 31, 2002), pp. 670-675, 45:3.
Takanashi, H, et al., Selective motilin receptor antagonist in the smooth muscle of the rabbit small intestine, Journal of Phamacology and Experimental Therapeutics (1995), pp. 624-628, 273:2.
Examination Report corresponding to European Application No. 04761605.7-1216 mailed Mar. 12, 2008.
Beaubien Sylvie
Benakli Kamel
Deslongchamps Pierre
Dory Yves
Fortin Daniel
Kosar Andrew D
Myers Bigel & Sibley Sajovec, PA
Tranzyme Pharma Inc.
LandOfFree
Conformationally-controlled biologically active macrocyclic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Conformationally-controlled biologically active macrocyclic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conformationally-controlled biologically active macrocyclic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4022698